NO145437C - ANALOGY PROCEDURE FOR PREPARING A PHYSIALLY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES - Google Patents

ANALOGY PROCEDURE FOR PREPARING A PHYSIALLY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES

Info

Publication number
NO145437C
NO145437C NO4290/73A NO429073A NO145437C NO 145437 C NO145437 C NO 145437C NO 4290/73 A NO4290/73 A NO 4290/73A NO 429073 A NO429073 A NO 429073A NO 145437 C NO145437 C NO 145437C
Authority
NO
Norway
Prior art keywords
physially
bifenylester
preparing
active
series
Prior art date
Application number
NO4290/73A
Other languages
Norwegian (no)
Other versions
NO145437B (en
Inventor
Michael Ross Johnson
Thomas Ken Schaaf
Jasjit Singh Bindra
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO145437B publication Critical patent/NO145437B/en
Publication of NO145437C publication Critical patent/NO145437C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
NO4290/73A 1972-11-08 1973-11-07 ANALOGY PROCEDURE FOR PREPARING A PHYSIALLY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES NO145437C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481572A 1972-11-08 1972-11-08

Publications (2)

Publication Number Publication Date
NO145437B NO145437B (en) 1981-12-14
NO145437C true NO145437C (en) 1982-03-24

Family

ID=23178143

Family Applications (2)

Application Number Title Priority Date Filing Date
NO4290/73A NO145437C (en) 1972-11-08 1973-11-07 ANALOGY PROCEDURE FOR PREPARING A PHYSIALLY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES
NO743588A NO146280C (en) 1972-11-08 1974-10-03 BIS-TETRAHYDROPYRANYLETERS FOR USE AS INTERMEDIATE FOR PREPARING A PHYSIOLOGY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO743588A NO146280C (en) 1972-11-08 1974-10-03 BIS-TETRAHYDROPYRANYLETERS FOR USE AS INTERMEDIATE FOR PREPARING A PHYSIOLOGY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES

Country Status (24)

Country Link
JP (1) JPS5644068B2 (en)
AR (2) AR204816A1 (en)
AT (1) AT347607B (en)
BE (1) BE807047A (en)
CA (1) CA1027559A (en)
CH (1) CH601222A5 (en)
CS (1) CS188175B2 (en)
DD (2) DD113211A5 (en)
DE (2) DE2355042A1 (en)
ES (2) ES420326A1 (en)
FI (1) FI58116C (en)
FR (2) FR2205339B1 (en)
GB (1) GB1456511A (en)
HU (2) HU171945B (en)
IE (1) IE39686B1 (en)
IL (1) IL43553A (en)
IN (1) IN139905B (en)
NL (1) NL7315240A (en)
NO (2) NO145437C (en)
PH (2) PH15504A (en)
SE (2) SE420198B (en)
SU (2) SU538659A3 (en)
YU (2) YU287973A (en)
ZA (1) ZA738593B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2361410A1 (en) * 1972-07-13 1978-03-10 Pfizer DIALKYL ALKYLPHOSPHONATES, USEFUL AS PROSTAGLANDIN SYNTHESIS INTERMEDIARIES
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
US3998869A (en) * 1974-11-14 1976-12-21 The Upjohn Company Substituted anilide esters of 16-substituted PGE2
DE2737807A1 (en) * 1976-08-27 1978-03-09 Pfizer C LOW 1 -P-BIPHENYLESTER OF OMEGA-PENTANORPROSTAGLANDINES
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure

Also Published As

Publication number Publication date
DD113211A5 (en) 1975-05-20
CH601222A5 (en) 1978-06-30
DE2355042A1 (en) 1974-05-22
HU171945B (en) 1978-04-28
FR2205339B1 (en) 1980-01-04
FI58116C (en) 1980-12-10
FR2275452A1 (en) 1976-01-16
SE7704369L (en) 1977-04-15
IL43553A (en) 1979-10-31
NO146280B (en) 1982-05-24
IE39686L (en) 1974-05-08
IN139905B (en) 1976-08-14
NO146280C (en) 1982-09-01
NO145437B (en) 1981-12-14
CA1027559A (en) 1978-03-07
FR2275452B1 (en) 1977-12-16
HU171818B (en) 1978-03-28
AT347607B (en) 1979-01-10
FR2205339A1 (en) 1974-05-31
SE420198B (en) 1981-09-21
NO743588L (en) 1974-05-09
AR202311A1 (en) 1975-05-30
PH15504A (en) 1983-02-03
FI58116B (en) 1980-08-29
ES420326A1 (en) 1976-03-16
PH13794A (en) 1980-10-01
IE39686B1 (en) 1978-12-06
ES434687A1 (en) 1976-12-16
SU538659A3 (en) 1976-12-05
YU264480A (en) 1983-04-27
AR204816A1 (en) 1976-03-05
NL7315240A (en) 1974-05-10
AU6222573A (en) 1975-05-08
DE2365999A1 (en) 1977-05-12
GB1456511A (en) 1976-11-24
CS188175B2 (en) 1979-02-28
JPS49100060A (en) 1974-09-20
SU1021340A3 (en) 1983-05-30
ATA937173A (en) 1978-05-15
BE807047A (en) 1974-05-08
JPS5644068B2 (en) 1981-10-16
YU287973A (en) 1982-02-25
ZA738593B (en) 1974-10-30
DD111370A5 (en) 1975-02-12
IL43553A0 (en) 1974-03-14

Similar Documents

Publication Publication Date Title
NO139072C (en) PROCEDURE FOR THE PREPARATION OF A PET PET PRODUCT
NO139689C (en) PROCEDURE FOR THE MANUFACTURE OF LATEX
NO157933C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE CEFEM COMPOUNDS.
SE407579B (en) PROCEDURE FOR THE PREPARATION OF N-PHOSPHONOMETHYLGLICIN
NO144223C (en) PROCEDURE FOR THE MANUFACTURING OF EXTENSIVE PAPER
NO143663C (en) ANALOGY PROCEDURE FOR PREPARING A PHYSIOLOGY ACTIVE PROSTAGLAND CONNECTION OF THE E OR F SERIES
SE410447B (en) HALOGENACETONILIDES FOR INFLUENCE OF PLANT GROWTH
SE390114B (en) PROCEDURE FOR EVAPORATION OF A VETSKA
SE448992B (en) PROCEDURE FOR PREPARING AN OMEGA-PENTANOR PROSTAGLANDIN FROM THE E OR F SERIES
SE399423B (en) PROCEDURE FOR PRODUCTION OF PROSTAGLAND INNALOGES
NO153573C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE N-ACYLAMINO-ALFA-ARYLACET-AMIDOCEPHALOSPORINES.
NO142033C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTICALLY ACTIVE ISOPROPYLAMINO-3-PHENOXYPROPANOLS
SE392609B (en) PROCEDURE FOR THE PRODUCTION OF METHANE - GASES
NO144830C (en) SUBSTITUTED CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE BY PREPARING A PHYSIOLOGY ACTIVE PROSTAGLAND CONNECTION OF THE E OR F SERIES
SE7611202L (en) PROCEDURE FOR PREPARING PYRAZOLODIAZEPINE COMPOUNDS
SE397201B (en) PROCEDURE FOR THE PREPARATION OF GLUCOSISOMERAS FROM A MICRO-ORGANISM OF THE GENEAL ACTIONOPLANES
NO145437C (en) ANALOGY PROCEDURE FOR PREPARING A PHYSIALLY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES
SE7609048L (en) PROCEDURE FOR PRODUCTION OF PROSTAGLANDINS
SE404525B (en) PROCEDURE FOR THE PREPARATION OF 4-AMINOMETHYL-CYCLOHEXANE-CARBOXYLIC ACID-1
SE403108B (en) PROCEDURE FOR THE PREPARATION OF A FLAVANON DERIVATIVE FROM ONE OF LIQUORITE ROOT RECOVERED STARTING MATERIAL
SE385123B (en) METHODS OF MANUFACTURING RACEMIC OR OPTICALLY ACTIVE 13BETA-ETHYL-17ALFA-ETHYNYL-GON-4-EN-3-ON-17BETA-OL
FI56670B (en) PROCEDURE FOR FRAMSTATION OF AV 5-CYCLOHEXYL-6-HALOGENINDAN-1-CARBOXYLSYRADERIVAT
SE398500B (en) PROCEDURE FOR THE PREPARATION OF 2- (3-LEGER ALKYLAMINO-2-HYDROXIPROPYL) -3-PHENYLPYRAZINE
DK551178A (en) ANALOGICAL PROCEDURE FOR THE PRODUCTION OF PROSTAGLANDIN ANALOG
SE395005B (en) PROCEDURE FOR THE PREPARATION OF 1-ARYLIDENAMINO-4- (2-OXO-3-PHENYL-3-BENZOFURYL) -PIPERAZINES